| Literature DB >> 34036532 |
Elizabeth A Hall1, Hannah E Sauer2, Margaret S Davis3, Doralina L Anghelescu4.
Abstract
Lidocaine is an amino amide with a well-established role as a local anesthetic agent. Systemic intravenous administration expands its clinical use to include acute and chronic pain circumstances, such as postoperative pain, neuropathic pain, postherpetic neuralgia, hyperalgesia, visceral pain, and centrally mediated pain. For refractory pain that has not responded to conventional therapy or if further escalation of treatment is prevented by contraindications or side effects to standard therapies, a continuous infusion of lidocaine may be considered as a single intervention or as a sequence of infusions. Here, we review and evaluate published data reflecting the use of lidocaine continuous infusions for pain management in the pediatric population.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34036532 PMCID: PMC8609473 DOI: 10.1007/s40272-021-00454-2
Source DB: PubMed Journal: Paediatr Drugs ISSN: 1174-5878 Impact factor: 3.930